Efficacy and return on investment of RHINISENG® in two farms affected by atrophic rhinitis in Russia

Inicio Conocimiento Efficacy and return on investment of RHINISENG® in two farms affected by atrophic rhinitis in Russia

Efficacy and return on investment of RHINISENG® in two farms affected by atrophic rhinitis in Russia

Atrophic Rhinitis (AR) is present in all countries with swine production. Although clear clinical symptoms are sometimes difficult to see, AR causes very important productive losses. The objective of this study is to evaluate growth improvement of fattening pigs after vaccination against AR. 

Sobre este artículo

Apareció en

IPVS Congress China, 2018

Fecha

12 jul. 2018

Autores

Martos, A.; Dudar, L.; Polutov, D.; Vasyliv, A.

Resumen

The results demonstrate that vaccination with RHINISENG® can prevent infections by AR and its resulting losses in productivity.

Productos relacionados

Compartir en